OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SYCH56

Syschem (India) Ltd

Diversified ChemicalsVerified

Syschem (India) Ltd exhibits a weak capital structure and liquidity position, with a negative operating cash flow of INR 256.5 million and a negative net income of INR 2.6 million. The company's liquidity is further constrained by a current ratio of 1.31, indicating limited short-term liquidity to cover its obligations. The debt-to-equity ratio of 0.01 suggests a relatively low leverage position, but the negative net cash position after subtracting total debt raises concerns about its ability to fund operations without external financing. Profitability metrics are underperforming relative to industry norms, with a return on equity of -0.46% and a return on assets of -0.16%. These figures indicate that the company is not generating returns that meet the cost of capital, which is a red flag for investors. The operating margin, calculated as operating income of INR 9.5 million on revenue of INR 880 million, is a mere 1.09%, which is likely below the median for the Diversified Chemicals industry. The company's revenue is concentrated in a few key segments, with the pharmaceutical and agrochemical industries being the primary markets. However, the input data does not provide a breakdown of revenue by geographic region or segment, making it difficult to assess the extent of geographic or product diversification. This lack of transparency could obscure potential concentration risks. Looking ahead, the company's growth trajectory appears uncertain. The input data does not provide forward-looking revenue guidance or outlook for the next fiscal year, but the negative operating cash flow and net loss suggest that the company may face challenges in sustaining or growing its revenue in the near term. The capital expenditure of INR 66.8 million indicates some level of investment in operations, but the negative net income raises questions about the sustainability of such investments. Risk factors for the company include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's negative net cash position and reliance on operating cash flow, which has been negative, suggest that it may need to raise additional capital in the future, which could lead to share dilution. The risk assessment also highlights the need for close monitoring of the company's liquidity position and its ability to generate positive cash flows from operations. Recent events and filings do not provide specific details on strategic initiatives or major operational changes, but the negative net income and operating cash flow suggest that the company may be facing operational or market challenges. The absence of detailed information on recent events or strategic moves limits the ability to assess the company's response to these challenges.

30-day price · SYCH+3.27 (+7.3%)
Low$43.01High$54.90Close$48.13As of15 May, 00:00 UTC
Profile
CompanySyschem (India) Ltd
TickerSYCH.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Syschem (India) Ltd is a diversified chemicals company engaged in the production and distribution of specialty chemicals, primarily serving the pharmaceutical and agrochemical industries.

Classification. Syschem is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

Syschem (India) Ltd exhibits a weak capital structure and liquidity position, with a negative operating cash flow of INR 256.5 million and a negative net income of INR 2.6 million. The company's liquidity is further constrained by a current ratio of 1.31, indicating limited short-term liquidity to cover its obligations. The debt-to-equity ratio of 0.01 suggests a relatively low leverage position, but the negative net cash position after subtracting total debt raises concerns about its ability to fund operations without external financing. Profitability metrics are underperforming relative to industry norms, with a return on equity of -0.46% and a return on assets of -0.16%. These figures indicate that the company is not generating returns that meet the cost of capital, which is a red flag for investors. The operating margin, calculated as operating income of INR 9.5 million on revenue of INR 880 million, is a mere 1.09%, which is likely below the median for the Diversified Chemicals industry. The company's revenue is concentrated in a few key segments, with the pharmaceutical and agrochemical industries being the primary markets. However, the input data does not provide a breakdown of revenue by geographic region or segment, making it difficult to assess the extent of geographic or product diversification. This lack of transparency could obscure potential concentration risks. Looking ahead, the company's growth trajectory appears uncertain. The input data does not provide forward-looking revenue guidance or outlook for the next fiscal year, but the negative operating cash flow and net loss suggest that the company may face challenges in sustaining or growing its revenue in the near term. The capital expenditure of INR 66.8 million indicates some level of investment in operations, but the negative net income raises questions about the sustainability of such investments. Risk factors for the company include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's negative net cash position and reliance on operating cash flow, which has been negative, suggest that it may need to raise additional capital in the future, which could lead to share dilution. The risk assessment also highlights the need for close monitoring of the company's liquidity position and its ability to generate positive cash flows from operations. Recent events and filings do not provide specific details on strategic initiatives or major operational changes, but the negative net income and operating cash flow suggest that the company may be facing operational or market challenges. The absence of detailed information on recent events or strategic moves limits the ability to assess the company's response to these challenges.
Key takeaways
  • Syschem (India) Ltd is experiencing negative net income and operating cash flow, indicating financial distress.
  • The company's return on equity and return on assets are negative, suggesting poor capital efficiency.
  • The company's liquidity position is weak, with a current ratio of 1.31 and negative net cash after debt.
  • The company's growth trajectory is uncertain, with no clear guidance on future revenue or profitability.
  • The risk of dilution is currently low, but the company may need to raise capital in the future to fund operations.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$880.0M
Gross profit$83.3M
Operating income$9.5M
Net income-$2.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$256.5M
CapEx-$66.8M
Free cash flow
Total assets$1.64B
Total liabilities$1.07B
Total equity$569.6M
Cash & equivalents$957.0k
Long-term debt$4.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$744.1M-$72.4M-$55.7M-$83.2M
FY-3$656.3M-$20.2M-$17.1M-$35.4M
FY-2$1.30B$59.4M$45.1M$52.6M
FY-1$2.33B$42.0M$27.6M-$11.3M
FY0$3.86B$10.4M$4.6M-$183.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$771.7M$71.2M$241.0k
FY-3$598.1M$69.4M$274.0k
FY-2$927.1M$223.0M$5.7M
FY-1$1.64B$569.6M$957.0k
FY0$2.17B$912.9M$21.4M
PeriodOCFCapExFCFSBC
FY-4$37.2M-$51.1M-$83.2M
FY-3$10.7M-$44.1M-$35.4M
FY-2-$84.9M-$19.6M$52.6M
FY-1-$256.5M-$66.8M-$11.3M
FY0-$100.9M-$217.2M-$183.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$880.0M$9.5M-$2.6M
FQ-6$1.02B$1.3M$1.4M
FQ-5$542.1M-$6.1M-$6.4M
FQ-4$911.3M$5.2M$5.0M
FQ-3$1.39B$9.9M$4.6M
FQ-2$1.27B$17.1M$16.7M
FQ-1$1.18B$25.5M$19.0M
FQ0$1.62B$51.4M$41.7M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.64B$569.6M$957.0k
FQ-6
FQ-5$1.17B$564.5M$926.0k
FQ-4
FQ-3$2.17B$912.9M$21.4M
FQ-2
FQ-1$1.82B$948.6M$44.1M
FQ0
PeriodOCFCapExFCFSBC
FQ-7-$256.5M-$66.8M
FQ-6
FQ-5$158.9M-$158.9M
FQ-4
FQ-3-$100.9M-$217.2M
FQ-2
FQ-1$132.4M-$109.2M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$569.6M
Net cash-$3.5M
Current ratio1.3
Debt/Equity0.0
ROA-0.2%
ROE-0.5%
Cash conversion97.2%
CapEx/Revenue-7.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 83 companies
MetricSYCHActivity
Op margin1.1%6.3% medp25 2.1% · p75 9.6%bottom quartile
Net margin-0.3%3.3% medp25 0.2% · p75 6.4%bottom quartile
Gross margin9.5%23.5% medp25 13.2% · p75 31.9%bottom quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-7.6%-5.5% medp25 -11.2% · p75 -3.8%below median
Debt / equity1.0%42.1% medp25 16.7% · p75 82.4%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 00:56 UTC#377854f0
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 15:26 UTCJob: ea548b06